Important Content Reminder:
- The company's stock has been hitting the daily price limit since February 10, 2026, with significant price fluctuations after excluding overall market factors, indicating risks of market over-excitement and irrational speculation. The company has recently disclosed multiple announcements regarding abnormal trading fluctuations, risks of potential delisting, and updates on investigations, urging investors to make rational investment decisions and be cautious to avoid significant risks in the secondary market.
- Since April 30, 2025, the company has been under delisting risk warning, with its stock name changed from "WanFang Development" to "*ST WanFang," while the stock code remains "000638," and the daily price fluctuation limit is set at 5%. For details, please refer to the announcement disclosed on April 29, 2025, regarding the delisting risk warning and suspension of trading (Announcement No. 2025-031).
- On January 31, 2026, the company disclosed its 2025 performance forecast, estimating the following key financial indicators:
Indicator Range Operating Revenue 200 million to 250 million yuan Net Profit Attributable to Shareholders -50 million to -35 million yuan Total Profit -55 million to -40 million yuan Net Profit After Non-recurring Gains and Losses -22 million to -15 million yuan The company expects negative values for total profit, net profit attributable to shareholders, and net profit after non-recurring gains and losses, with operating revenue below 300 million yuan. According to the Shenzhen Stock Exchange Listing Rules, the company's stock will be delisted due to financial criteria. Investors are advised to pay attention to related risks and make rational decisions. - Zhongxing Caiguanghua Accounting Firm (Special General Partnership) audited the company's 2024 financial statements and issued a qualified opinion audit report (Zhongxing Caiguanghua Audit No. (2025) 207002), indicating uncertainty regarding the recoverability of investments in other equity instruments of Jilin WanFang Bai'ao Biotechnology Co., Ltd. As of the date of this announcement, the uncertainty has not been resolved, and there remains a risk of a qualified opinion audit report for the 2025 financial statements. If a qualified opinion audit report is issued for 2025, the company's stock will be delisted according to the Shenzhen Stock Exchange Listing Rules. Investors are urged to be aware of related risks and make rational decisions.
- On July 25, 2025, the company received a notice from the China Securities